Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atsushi Noda

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Journal of Exercise Rehabilitation|September 8, 2025
Effects of modified sit-to-stand training on load asymmetry in patients with hip fracture: a pilot quasi-randomized controlled trialAtsushi Noda, Akira Ochi
Epilepsy Research|June 22, 2014
Effects of conventional anticonvulsant drugs on generalized tonic-clonic seizures in Noda epileptic ratsMaki Inoue, Ayaka Yamamoto, Yuka Kaneko, et al.
Neural Computation|April 9, 2014
Intrinsic graph structure estimation using graph LaplacianAtsushi Noda, Hideitsu Hino, Masami Tatsuno, et al.
Reproductive Toxicology (Elmsford, N.Y.)|January 15, 2008
Reproductive and developmental toxicity screening test of tetrahydrofurfuryl alcohol in ratsMutsuko Hirata-Koizumi, Atsushi Noda, Akihiko Hirose, et al.
The Journal of Toxicological Sciences|June 25, 2003
Higher susceptibility of newborn than young rats to 3-methylphenolMutsuko Koizumi, Atsushi Noda, Yoshihiko Ito, et al.
Experimental Animals|May 14, 2023
Intraplacental injection of AAV9-CMV-iCre results in the widespread transduction of multiple organs in double-reporter mouse embryosNatalia Gogoleva, Zeynab Javanfekr Shahri, Atsushi Noda, et al.
Endocrine Research|February 5, 2013
Pharmacological Characterization of YM543, a Newly Synthesized, Orally Active SGLT2 Selective InhibitorMasanori Yokono, Atsuo Tahara, Eiji Kurosaki, et al.
Bioorganic & Medicinal Chemistry|February 26, 2022
Discovery of ASP5878: Synthesis and structure-activity relationships of pyrimidine derivatives as pan-FGFRs inhibitors with improved metabolic stability and suppressed hERG channel inhibitory activityIkumi Kuriwaki, Minoru Kameda, Kazuhiko Iikubo, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 6, 2011
Pharmacological profile of ipragliflozin (ASP1941), a novel selective SGLT2 inhibitor, in vitro and in vivoAtsuo Tahara, Eiji Kurosaki, Masanori Yokono, et al.
The Journal of Pharmacy and Pharmacology|February 19, 2014
Effects of sodium-glucose cotransporter 2 selective inhibitor ipragliflozin on hyperglycaemia, oxidative stress, inflammation and liver injury in streptozotocin-induced type 1 diabetic ratsAtsuo Tahara, Eiji Kurosaki, Masanori Yokono, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Journal of Exercise Rehabilitation|September 8, 2025
Effects of modified sit-to-stand training on load asymmetry in patients with hip fracture: a pilot quasi-randomized controlled trialAtsushi Noda, Akira Ochi
Epilepsy Research|June 22, 2014
Effects of conventional anticonvulsant drugs on generalized tonic-clonic seizures in Noda epileptic ratsMaki Inoue, Ayaka Yamamoto, Yuka Kaneko, et al.
Neural Computation|April 9, 2014
Intrinsic graph structure estimation using graph LaplacianAtsushi Noda, Hideitsu Hino, Masami Tatsuno, et al.
Reproductive Toxicology (Elmsford, N.Y.)|January 15, 2008
Reproductive and developmental toxicity screening test of tetrahydrofurfuryl alcohol in ratsMutsuko Hirata-Koizumi, Atsushi Noda, Akihiko Hirose, et al.
The Journal of Toxicological Sciences|June 25, 2003
Higher susceptibility of newborn than young rats to 3-methylphenolMutsuko Koizumi, Atsushi Noda, Yoshihiko Ito, et al.
Experimental Animals|May 14, 2023
Intraplacental injection of AAV9-CMV-iCre results in the widespread transduction of multiple organs in double-reporter mouse embryosNatalia Gogoleva, Zeynab Javanfekr Shahri, Atsushi Noda, et al.
Endocrine Research|February 5, 2013
Pharmacological Characterization of YM543, a Newly Synthesized, Orally Active SGLT2 Selective InhibitorMasanori Yokono, Atsuo Tahara, Eiji Kurosaki, et al.
Bioorganic & Medicinal Chemistry|February 26, 2022
Discovery of ASP5878: Synthesis and structure-activity relationships of pyrimidine derivatives as pan-FGFRs inhibitors with improved metabolic stability and suppressed hERG channel inhibitory activityIkumi Kuriwaki, Minoru Kameda, Kazuhiko Iikubo, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 6, 2011
Pharmacological profile of ipragliflozin (ASP1941), a novel selective SGLT2 inhibitor, in vitro and in vivoAtsuo Tahara, Eiji Kurosaki, Masanori Yokono, et al.
The Journal of Pharmacy and Pharmacology|February 19, 2014
Effects of sodium-glucose cotransporter 2 selective inhibitor ipragliflozin on hyperglycaemia, oxidative stress, inflammation and liver injury in streptozotocin-induced type 1 diabetic ratsAtsuo Tahara, Eiji Kurosaki, Masanori Yokono, et al.
Pageof 2